2022
Comparison of mental health outcomes of augmenting medications for patients with posttraumatic stress disorder: A national veterans affairs study
Ranney R, Maguen S, Woods A, Seal K, Neylan T, Bernardy N, Wiechers I, Ryder A, Cohen B. Comparison of mental health outcomes of augmenting medications for patients with posttraumatic stress disorder: A national veterans affairs study. Journal Of Evaluation In Clinical Practice 2022, 29: 191-202. PMID: 35709244, DOI: 10.1111/jep.13726.Peer-Reviewed Original ResearchConceptsEmergency room visitsPosttraumatic stress disorderPsychiatric emergency room visitsAugmenting medicationsRoom visitsMental health outcomesPsychiatric hospitalizationHospitalization/emergency room visitsHealth outcomesStress disorderPTSD symptomsVeterans Affairs studyDiagnosis of PTSDMedication groupClinical trialsAdditional interventionsMedicationsBaseline levelsPatientsVeterans AffairsNew prescriptionsElectronic recordsVisitsHospitalizationSymptoms
2016
No End in Sight: Benzodiazepine Use in Older Adults in the United States
Maust DT, Kales HC, Wiechers IR, Blow FC, Olfson M. No End in Sight: Benzodiazepine Use in Older Adults in the United States. Journal Of The American Geriatrics Society 2016, 64: 2546-2553. PMID: 27879984, PMCID: PMC5173408, DOI: 10.1111/jgs.14379.Peer-Reviewed Original ResearchConceptsMental health diagnosesBenzodiazepine useBenzodiazepine usersOlder adultsNonpsychiatrist physiciansNational Ambulatory Medical Care SurveyVisit ratesAmbulatory Medical Care SurveyAnnual visit rateHealth diagnosisEffective alternative treatmentCross-sectional analysisPatient ageOutpatient encountersClinical mental health diagnosisCare SurveyVisit characteristicsChronic usersAlternative treatmentYoung adultsVisitsDecades of evidenceOverall proportionAdultsSafety concerns